The company is undertaking a massive acquisition, requiring significant new debt financing and subsequent integration.
Filing excerpt
On January 15, 2026, we announced our entry into a definitive agreement to acquire 100 percent of Penumbra, Inc. (Penumbra), a publicly traded medical technology company... At the time of announcement, the purchase price was valued at $374 per share, or approximately $14.500 billion.
What this signalsFilings often name leadership changes, deals and spending plans.
Competitors
Competitors named
sec-10qdebtRefinancingGet every 10-Q signal for Boston Scientific and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Boston Scientific this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/5ee5a4a0-b142-4e8b-a37a-9d93d4e0294a returns this record as JSON. POST /v1/companies/enrich returns every signal for bostonscientific.com.
{
"signal_id": "5ee5a4a0-b142-4e8b-a37a-9d93d4e0294a",
"signal_type": "sec-10q",
"signal_subtype": "debtRefinancing",
"detected_at": "2026-05-05T08:48:21.792+00:00",
"company": {
"name": "Boston Scientific",
"domain": "bostonscientific.com"
},
"data": {
"detail": "The company is undertaking a massive acquisition, requiring significant new debt financing and subsequent integration. This creates major opportunities for financial services, treasury management, and M&A integration consultants and software providers.",
"metrics": {
"timeframe": "current_year",
"dollar_context": "newly issued debt to fund Penumbra acquisition",
"dollar_millions": 11000
},
"summary": "Planning to raise ~$11B in new debt to fund $14.5B acquisition of Penumbra, Inc.",
"excerpts": "On January 15, 2026, we announced our entry into a definitive agreement to acquire 100 percent of Penumbra, Inc. (Penumbra), a publicly traded medical technology company... At the time of announcement, the purchase price was valued at $374 per share, or approximately $14.500 billion.",
"relevance": 0.95,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/885725/000088572526000033/bsx-20260331.htm",
"filing_date": "2026-05-01",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "03/31",
"sales_relevance": "Capital available or pressure",
"signal_category": "financial",
"competitors_mentioned": [
"Penumbra, Inc."
]
}
}
curl https://signals.autobound.ai/v1/signals/5ee5a4a0-b142-4e8b-a37a-9d93d4e0294a \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bostonscientific.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.